Fri, April 25, 2025
Thu, April 24, 2025
Wed, April 23, 2025
Tue, April 22, 2025
Mon, April 21, 2025
Sun, April 20, 2025
Sat, April 19, 2025
Fri, April 18, 2025
Thu, April 17, 2025
Wed, April 16, 2025
Tue, April 15, 2025
Mon, April 14, 2025
Sun, April 13, 2025
Sat, April 12, 2025
Fri, April 11, 2025
Thu, April 10, 2025
Wed, April 9, 2025
Tue, April 8, 2025
Mon, April 7, 2025
Sun, April 6, 2025

GeneDx CEO was influenced by her family's cystic fibrosis


  Copy link into your clipboard //business-finance.news-articles.net/content/202 .. -influenced-by-her-family-s-cystic-fibrosis.html
  Print publication without navigation Published in Business and Finance on by Fortune

Katherine Stueland is CEO of the publicly traded genetic testing business GeneDx.

The article from Fortune, published on March 31, 2025, features an interview with the CEO of GeneDx, a leading genetic testing company. The CEO discusses the company's focus on expanding access to genetic testing, particularly for rare diseases, and highlights recent advancements in their technology that have improved the accuracy and speed of their tests. Additionally, the CEO emphasizes the importance of diversity in the tech industry, sharing personal experiences as a woman in tech and discussing initiatives GeneDx has implemented to support and empower women within the company. The interview also touches on the broader impact of genetic testing on personalized medicine and the potential for future innovations in the field.

Read the Full Fortune Article at:
[ https://fortune.com/2025/03/31/genedx-ceo-genetic-testing-women-in-tech/ ]

Publication Contributing Sources